Results 1 to 10 of about 12,784,255 (313)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

open access: yesMolecular Cancer, 2023
The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression.
A. Glaviano   +26 more
semanticscholar   +1 more source

Gene expression profiles of breast cancer metastasis according to organ site

open access: yesMolecular Oncology, 2022
In advanced breast cancer, biomarker identification and patient selection using a metastatic tumor biopsy is becoming more necessary. However, the biology of metastasis according to the organ site is largely unknown.
Fara Brasó‐Maristany   +21 more
doaj   +1 more source

Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies

open access: yesSignal Transduction and Targeted Therapy, 2023
The ever-increasing prevalence of noncommunicable diseases (NCDs) represents a major public health burden worldwide. The most common form of NCD is metabolic diseases, which affect people of all ages and usually manifest their pathobiology through life ...
Xiumei Wu   +6 more
semanticscholar   +1 more source

Signaling pathways and targeted therapies for psoriasis

open access: yesSignal Transduction and Targeted Therapy, 2023
Psoriasis is a common, chronic, and inflammatory skin disease with a high burden on individuals, health systems, and society worldwide. With the immunological pathologies and pathogenesis of psoriasis becoming gradually revealed, the therapeutic ...
Jia Guo   +5 more
semanticscholar   +1 more source

Hedgehog signaling in tissue homeostasis, cancers and targeted therapies

open access: yesSignal Transduction and Targeted Therapy, 2023
The past decade has seen significant advances in our understanding of Hedgehog (HH) signaling pathway in various biological events. HH signaling pathway exerts its biological effects through a complex signaling cascade involved with primary cilium.
J. Jing   +6 more
semanticscholar   +1 more source

Efficacy of washed microbiota transplantation for therapeutic targets of refractory functional constipation and the influencing factors: a single-center, retrospective, 24-week follow-up study

open access: yesBMC Gastroenterology, 2023
Background The efficacy of washed microbiota transplantation (WMT) in terms of refractory functional constipation (FC)-related therapeutic targets and influencing factors have not been elucidated.
Liquan Wu   +11 more
doaj   +1 more source

Recent advances in targeted therapies in acute myeloid leukemia

open access: yesJournal of Hematology & Oncology, 2023
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has improved nearly sixfold with the optimization of intensive induction chemotherapy and allogeneic stem cell ...
R. Bhansali, K. Pratz, Catherine Lai
semanticscholar   +1 more source

Wnt/β-catenin signaling in cancers and targeted therapies

open access: yesSignal Transduction and Targeted Therapy, 2021
Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental cancer models of animals. Aberrant activation of Wnt/β-catenin signaling is tightly linked with the increment of prevalence, advancement of malignant progression ...
Fan-Yuan Yu   +8 more
semanticscholar   +1 more source

Gut microbiome-targeted therapies for Alzheimer’s disease

open access: yesGut microbes, 2023
The advent of highthroughput ‘omics’ technologies has improved our knowledge of gut microbiome in human health and disease, including Alzheimer’s disease (AD), a neurodegenerative disorder.
Tao Zhang   +3 more
semanticscholar   +1 more source

Emerging Targeted Therapies for HER2-Positive Breast Cancer

open access: yesCancers, 2023
Simple Summary HER2-positive breast cancer (BC), which accounts for ~20% of BC, is one of the more aggressive and has the worst overall survival rate among them.
M. Mercogliano   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy